(Press-News.org) Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it.
The two genes discovered actively ‘work’ in most human cancer types, meaning the findings could potentially extend to other cancers with elevated levels of the genes.
The researchers also looked through a chemical library, commonly used for drug discovery, and found two substances that could target the two genes specifically and make resistant cancer cells almost 30 times more sensitive to a common chemotherapy drug called cisplatin. They do this by reducing the levels of the two genes and could be given alongside existing chemotherapy treatment such as cisplatin. One of these substances is a fungal toxin - Sirodesmin A - and the other – Carfilzomib - comes from a bacterium. This shows that there may be existing drugs that can be repurposed to target new causes of disease, which can be cheaper than having to develop and produce new ones.
The research, led by Queen Mary and published in Molecular Cancer, is the first evidence for the genes NEK2 and INHBA causing chemoresistance in head and neck squamous cell carcinoma (HNSCC) and gene silencing of either gene overturning chemoresistance to multiple drugs.
The scientists first used a method known as data mining to identify genes that may be affecting tumour responsiveness to drug therapy. They tested 28 genes on 12 strains of chemoresistant cancer cell lines, finding 4 ‘significant’ genes that were particularly responsive that they then investigated further and tested multidrug-resistance.
Dr Muy-Teck Teh, senior author of the study from Queen Mary University of London, said: “These results are a promising step towards cancer patients in the future receiving personalised treatment based on their genes and tumour type that give them a better survival rate and treatment outcome.
“Unfortunately, there are lots of people out there who do not respond to chemotherapy or radiation. But our study has shown that in head and neck cancers at least it is these two particular genes that could be behind this, which can then be targeted to fight against chemoresistance.
“Treatment that doesn’t work is damaging both for the NHS and patients themselves. There can be costs associated with prolonged treatment and hospital stays, and it’s naturally extremely difficult for people with cancer when their treatment doesn’t have the results they are hoping for.”
90% of all head and neck cancers are caused by HNSCCs, with tobacco and alcohol use being key associations. There are 12,422 new cases of head and neck cancer each year, and the overall 5-year survival rate of patients with advanced HNSCC is less than 25%. A major cause of poor survival rates of HNSCC is because of treatment failure that stems from resistance to chemotherapy and/or radiotherapy.
Unlike lung and breast cancer patients, all HNSCC patients are treated with almost the same combinations of treatment irrespective of the genetic makeup of their cancer.
END
New genes and natural toxins offer hope for cancer patients unresponsive to chemotherapy
2023-09-04
ELSE PRESS RELEASES FROM THIS DATE:
Better cybersecurity with new material
2023-09-04
Digital information exchange can be safer, cheaper and more environmentally friendly with the help of a new type of random number generator for encryption developed at Linköping University, Sweden. The researchers behind the study believe that the new technology paves the way for a new type of quantum communication.
In an increasingly connected world, cybersecurity is becoming increasingly important to protect not just the individual, but also, for example, national infrastructure and banking systems. And there is an ongoing race between hackers and those trying to protect information. The most common way ...
People with lung conditions face extra risks from climate change
2023-09-04
People living with lung conditions, such as asthma and chronic obstructive pulmonary disease (COPD), face even greater risks from climate change, according to an expert report published today (Monday) in the European Respiratory Journal [1].
The report brings together evidence on how the effects of climate change, such as heatwaves, wildfires and flooding, will exacerbate breathing difficulties for millions of people around the world, particularly babies, young children and the elderly.
On behalf of the European Respiratory Society, which represents more than 30,000 lung specialists from 160 countries, the authors ...
ChatGPT is debunking myths on social media around vaccine safety, say experts
2023-09-04
ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics.
The researchers asked the artificial intelligence (AI) chatbot the top 50 most frequently-asked Covid-19 vaccine questions. They included queries based on myths and fake stories such as the vaccine causing Long Covid.
Results show that ChatGPT scored nine out of 10 on average for accuracy. The rest of the time it was correct but left some gaps in the information provided, according to the study.
Based on these findings, experts who led the study from the GenPoB research group based ...
Growing evidence supporting the protein leverage hypothesis
2023-09-04
Humans, like many other species, regulate protein intake more strongly than any other dietary component and so if protein is diluted there is a compensatory increase in food intake. The hypothesis proposes that the dilution of protein in modern-day diets by fat and carbohydrate-rich processed foods is driving increased energy intake as the body seeks to satisfy its natural protein drive - eating unnecessary calories until it does so.
This paper, resulting from the Royal Society Discussion Meeting held in London last October, shows that observational, experimental and mechanistic research increasingly supports ...
Why breast cancer survivors don't take their medication, and what can be done
2023-09-02
For roughly 80% of breast cancer survivors, treatment doesn’t end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend that they take medication to block sex hormones, which can fuel tumor growth and spark recurrence.
The drugs are life-saving: They’ve been shown to cut risk of cancer recurrence by as much as half in patients with hormone receptor-positive tumors (HR+)—the most common form of breast cancer. Yet despite their promised benefits, 40% of patients stop taking them early and a third ...
New scalable, etching-based technique for precise tuning of microdisk lasers
2023-09-02
Micro- and nanodisk lasers have recently emerged as promising optical sources and probes for various applications in the fields of nanophotonics and biomedicine. Their ability to achieve lasing at a deterministic wavelength and ultra-narrowband precision is critical for several applications in on-chip photonic communications, on-chip bioimaging, biochemical sensing, and quantum photonic information processing. However, the large-scale fabrication of such precise wavelength micro- and nanodisk lasers remains challenging. Current nanofabrication processes introduce randomness in ...
Seismologists use deep learning for improved earthquake forecasting
2023-09-02
For more than 30 years, the models that researchers and government agencies use to forecast earthquake aftershocks have remained largely unchanged. While these older models work well with limited data, they struggle with the huge seismology datasets that are now available.
To address this limitation, a team of researchers at the University of California, Santa Cruz and the Technical University of Munich created a new model that uses deep learning to forecast aftershocks: the Recurrent Earthquake foreCAST (RECAST). In a paper published today in Geophysical Research Letters, the scientists show how the deep learning model is more flexible ...
Software developed at UC Davis analyzes calcium ‘sparks’ that can contribute to arrhythmia
2023-09-01
(SACRAMENTO, Calif.) — A team of UC Davis and University of Oxford researchers have developed an innovative tool: SparkMaster 2. The open-source software allows scientists to analyze normal and abnormal calcium signals in cells automatically.
Calcium is a key signaling molecule in all cells, including muscles like the heart. The new software enables the automatic analysis of distinct patterns of calcium release in cells. This includes calcium "sparks," microscopic releases of calcium within cardiac cells associated ...
Could insights from ants help people build better transportation networks?
2023-09-01
Key takeaways
Ants can either forage for food as individuals or recruit other members of their colonies to help search for or carry food back to their nests.
UCLA biologists found that the strategies ants use to forage play a bigger role in how they build their nests than innate, evolutionary “blueprints” do.
When building nests, ants strike a balance between transportation efficiency and architectural constraints. Researchers say that observation could help humans design more efficient transportation systems tailored to specific needs.
Could ants’ nests hold the secret to reducing traffic congestion on the 405 Freeway?
In a new study, UCLA biologists ...
Invasive spotted lanternfly may not damage hardwood trees as previously thought
2023-09-01
UNIVERSITY PARK, Pa. — In 2012, when the spotted lanternfly (Lycorma delicatula) arrived in the U.S. from its home in China, scientists, land managers, and growers were understandably concerned that the sap-feeding insect would damage native and commercial trees. New long-term research led by Penn State has discovered that hardwood trees, such as maple, willow and birch, may be less vulnerable than initially thought.
“Since the lanternfly was first introduced to the northeastern U.S., the question has been, ‘How at-risk are our forests?’ said Kelli Hoover, professor of entomology at Penn State. “So far, we haven't had a good answer. Our study is the first ...